MMP 2 and MMP 9 have been shown to potentiate the pro-angiogenic chemokines involved in vascular remodeling in patients with IPF (CXCL5 and CXCL8) [39–42]. The gene discussed is CXCL8; the disease is idiopathic pulmonary fibrosis.